Soligenix- Warrants (07/12/2021) Overview
Latest P/E ratio for Soligenix- Warrants (07/12/2021): -0.29 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.29
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for SNGXW is -0.29. That is below the Healthcare sector average of 25.72. Investors often review this figure alongside Soligenix- Warrants (07/12/2021)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, SNGXW currently prints -0.29 for P/E ratio, while the sector average sits near 25.72. That is roughly 101.1% below the sector mean. Large gaps often invite a closer look at Soligenix- Warrants (07/12/2021)'s growth, margins, and balance sheet.
A P/E ratio of -0.29 for Soligenix- Warrants (07/12/2021) is not 'good' or 'bad' on its own. Compare it with the peer average (25.72) and with SNGXW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting SNGXW's P/E ratio (-0.29), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Soligenix- Warrants (07/12/2021)'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
